企业简介：

正在迅速成长的杭州多禧生物科技有限公司位于中国的“天堂”城市杭州。公司由五位在美国生物制药界分别有二十多年经验的海归科学家创立，致力于研发新一代被誉为“生物导弹”的抗体-药物共轭体(ADC)抗癌药物，志在挽救成千上万癌症患者的生命。我们团队成员曾作为技术骨干为当今治疗乳腺癌最有效的ADC药物Kadcyla的成功上市做出重要贡献。拥有数项自主知识产权的多禧生物正在迅速成为本领域的全球领跑者之一，现在加盟本公司恰逢其时。如果您是有活力的、梦想成功的专业人士，杭州多禧生物科技有限公司将为您提供一片发现、应用和发展才能的沃土。Hangzhou DAC Biotech Co.，Ltd. is a rapidly growing start-up located in the “paradise” city of China. As a biotech company established by five oversea returnee scientists who each had more than 20 years of experience in the US pharmaceutical industry respectively, we focus on developing next generation antibody-drug conjugates (ADC) or so-called “biological missiles” for cancer treatment. The goal is to develop a technology to save hundreds and thousands of cancer patients’ lives. As key scientists in a pioneering ADC company previously, our team members had made crucial contributions to the success of Kadcyla, an ADC that is currently the most efficacious drug for the treatment of breast cancer. With several proprietary technologies and related patents in hand, our company is quickly becoming one of the global leaders in the development of ADC platform technology. It is an exciting time to work at Hangzhou DAC Biotech. If you are a dynamic, success-driven professional, our company is the place where you can identify, utilize and develop your talents.